# Trade Mark Journal No.2026/032 7 August 2026

## UK00004420807 24 July 2026 (5)

International priority date claimed: 24 February 2026 (United States of America) (99668479)

Class 5
  Pharmaceutical preparations for the treatment of Major Depressive Disorder and Excessive Daytime Sleepiness; Prescription medicines for the treatment of Major Depressive Disorder and Excessive Daytime Sleepiness.

Axsome Therapeutics, Inc.

Representative: Keltie LLP